Home / Markets / Industries / Health Care
Monday, October 12, 2009
Drug Stocks Inch Up; DepoMed Dives On Drug Data
By Val Brickates Kennedy
MarketWatch Pulse
BOSTON -- Drug stocks inched up in early action Monday as shares of DepoMed Inc. sank after it released mixed Phase III clinical data for its menopausal hotflash treatment Serada. Both the NYSE Pharmaceutical Index and the NYSE Arca Biotechnology Index were up marginally at 290.98 and 915.93, respectively. Shares of DepoMed were down around 34% at $4.18.
Copyright © 2009 MarketWatch, Inc.
